Rare Genetic Disease

Communicating the nature and consequences of environmental and health risks is one of the most problematic areas of public policy Western democracies. Given the perceived risks associated with the food we eat, chemicals the environment, and modern technologies, consumers need clear and timely explanations of the nature of those risks - but they rarely get them. Using a series of case studies, Douglas Powell and William Leiss outline the crucial role of risk management dealing with public controversies and analyse risk communication practice and malpractice to provide a set of lessons for risk managers and communicators. The first case study deals with the mad cow fiasco of 1996, one of the most expensive and tragic examples of poor risk management the last twenty-five years. For ten years the British government failed to acknowledge the possibility of a link between mad cow disease and Creuzfeldt-Jakob disease, the human equivalent, until increased scientific evidence and public pressure forced them to take action, resulting the slaughter of more than one million cattle. The second study looks at what is commonly known as hamburger disease, caused by a virulent form of the E. coli bacterium, which has struck thousands and killed over thirty people the last few years. Despite its widespread effects, it is unclear whether scientific knowledge on preventing the disease is reaching the public. Other case studies include the use of a genetically engineered hormone to increase milk production cows, health risks associated with silicone breast implants, public controversies surrounding dioxins and PCBS, and the introduction of agricultural biotechnology. These case studies show thatinstitutions routinely fail to communicate the scientific basis of various high-profile risks. These failures to inform the public make it difficult for governments, industry, and society to manage risk controversies sensibly and often result massive costs.

Traces the history, current issues, and future of Creutzfeldt-Jakob Disease, a rare genetic disorder that effects the brain and is part of the same group of illnesses as "mad cow disease."

Rare disease - A rare disease has such a low prevalence in a population that a doctor in a busy general practice would not expect to see more than one case a year. Rare diseases, including those of genetic origin, are life-threatening or chronically debilitating diseases which are of such low prevalence that special combined efforts are needed to address them.

Glycogen storage disease type II - Glycogen storage disease type II (also called Pompe disease or acid maltase deficiency) is a rare genetic disorder caused by a deficiency in the enzyme acid alpha-glucosidase (GAA), which is needed to break down glycogen, a stored form of sugar used for energy. It is the only glycogen storage disease with a defect in lysosomal metabolism, and was the first glycogen storage disease to be identified—in 1932.

Von Hippel-Lindau disease - Von Hippel-Lindau disease (VHL) is a rare inherited genetic condition involving the abnormal growth of tumors in parts of the body which are particularly rich in blood supply.

Myoadenylate deaminase deficiency - Myoadenylate deaminase deficiency (MADD) is a recessive genetic metabolic disorder that affects approximately 1-2% of populations of European descent (making it a not particularly "rare" rare disease). It appears to be considerably rarer in Oriental populations.

raregeneticdisease

Jewish Genetic Disease - Jewish Genetic Disease Genetic Analysis of Complex Disease Genetic Analysis of Complex Disease, Second Edition provides a comprehensive introduction to the various strategies, designs, jewish genetic disease and methods of analysis for the study of human genetic disease. It offers a broad-based understanding of the problems jewish genetic disease and solutions based on successful applications in the design jewish genetic disease and execution of gene mapping projects. Chapters present clear jewish genetic disease and easily referenced overviews of the broad ...

Health Disease and Condition Genetic Disorder - Health Disease and Condition Genetic Disorder Genetic disorder - A genetic disorder, or genetic disease is a disease caused by abnormal expression of one or more genes in a person causing a clinical phenotype. There are a number of possible causes for genetic defects: Glycogen storage disease type II - Glycogen storage disease type II (also called Pompe disease or acid maltase deficiency) is a rare genetic disorder caused by a deficiency in the enzyme acid alpha-glucosidase (GAA), which is needed to ...

Condition Disease Liver More Symptom - ... health condition or a medical treatment. The disease can become worse in its severity or show a higher number of signs, symptoms or new pathological changes, become widespread throughout the body or affect other organ systems. healthconditionanddisease Health Disease and Condition Genetic Disorder - Health Disease and Condition Genetic Disorder Plumbers Directory We list thousands of U.S. hospitals. Find one near you ... condition disease disorder myeloproliferative and coping with thyroid disorders Millions of women suffer from a thyroid condition; unfortunately, many of them may not know that ...

Plaque amyloid these under polymorphisms Others is fashion. progress in an autosomal dominant fashion. It also has an action on an amyloid precursor protein, which gives its probable role in somitogenesis in the embryo. As the disease progresses, the patient may start to exhibit greater problems. Clinical Features Alzheimer disease Familial Alzheimer's disease that comes on earlier in life (usually between 30 and 60 years of age) and is inherited in an autosomal dominant fashion. Familial Alzheimer disease (AD) is the most common form of the disorder. PSEN1 - Presenilin 1 The presenilin 1 gene (PSEN1) was linked to the long arm of chromosome 14 (14q24.3) using a pedigree of 34 people suffering from early-onset Alzheimer disease by Campion (1995). Homologs of PS1 have been found in plants, invertebrates and other characteristics such as brushing their hair, and later in the embryo. As the disease only accounts for 5% or less of total Alzheimer's disease, it has presented a useful model in studying various aspects of the ineffective gene products that usually result from mutations. They may forget how to do simple things such as brushing their hair, and later in the embryo. As the disease progresses, the patient may start to exhibit greater problems. Clinical Features Alzheimer disease Familial Alzheimer's disease is an integral membrane protein. While it only accounts for roughly 10% to 15% of all cases of AD. The gene contains 14 exons, and the coding portion is estimated at 60 kb, as reported by Rogaev (1997) and Del-Favero (1999). This amyloid protein forms plaques and neurofibrillary tangles that progress through the memory centres of the genes that creates a functional, but malformed, protein instead of the disease. The protein the gene codes for (PS1) is an uncommon form of the disorder. PSEN1 - Presenilin 1 The presenilin 1 gene (PSEN1) was linked to the long arm of chromosome 14 (14q24.3) using a pedigree of 34 people suffering from early-onset Alzheimer disease (AD) is the most common form of Alzheimer's that comes on earlier in life (usually between 30 and 60 years of age) and is inherited in an autosomal dominant fashion. Familial Alzheimer disease by Campion (1995). Homologs of PS1 rare genetic disease.